Departmental Affiliations
Gigi Kwik Gronvall, PhD '00, is an immunologist by training, who has written extensively about synthetic biology, preparations for bioterrorism, and the contested origin of SARS-CoV-2.
Contact Info
621 E. Pratt Street, Suite 210
Baltimore
Maryland
21202
US
Research Interests
health security; covid-19; immunology; synthetic biology; biosecurity; biosafety; ethics; preparedness; pandemics
Additional Links
Experiences & Accomplishments
Education
PhD
Johns Hopkins University
2000
BS
Indiana University
1993
Overview
Dr. Gronvall is a Senior Scholar at the Johns Hopkins Center for Health Security and an Associate Professor in the Department of Environmental Health and Engineering at the Bloomberg School of Public Health. She is an immunologist by training.
During the COVID-19 pandemic, she led the Center’s ongoing efforts to track the development and marketing of molecular and antigen tests and serology tests, as well as the development of national strategies for COVID-19 serology (antibody) tests and SARS-CoV-2 serosurveys in the United States. She also has written about the scientific response to the COVID-19 pandemic, the contested origin of SARS-CoV-2, and the implications for national and international security.
During the COVID-19 pandemic, she led the Center’s ongoing efforts to track the development and marketing of molecular and antigen tests and serology tests, as well as the development of national strategies for COVID-19 serology (antibody) tests and SARS-CoV-2 serosurveys in the United States. She also has written about the scientific response to the COVID-19 pandemic, the contested origin of SARS-CoV-2, and the implications for national and international security.
Select Publications
A sampling of recent publications and reports:
- Feasibility of a Health Security Center in Asia Findings from a feasibility study on the benefits and challenges of establishing a new health security center in Asia
- Summary of Expert Insights for the US Department of Defense Biodefense Posture Review Meeting Meeting report
- A Closing Window of Opportunity for Gene Drive Governance in the United States Health Secur. 2022 Jan-Feb;20(1):3-5
- The Need for a Tiered Registry for US Gene Drive Governance Health Secur. 2022 January
- The Contested Origin of SARS-CoV-2 Survival 2021;63(6)
Projects
Iraq Implementers Conference
International Biosafety Norms
PASCC US - India Biosecurity Dialogue
Red Teaming Global Catastrophic Biological Risks